We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

BioFire Diagnostics

BioFire Diagnostics, a subsidiary of bioMérieux SA, offers easy-to-use clinical molecular diagnostic solutions based ... read more Featured Products: More products

Download Mobile App




Rapid Methods Compared for Positive Blood Cultures

By LabMedica International staff writers
Posted on 20 May 2014
Print article
Image: FilmArray Direct from Positive Blood Culture Identification system (BCID) (Photo courtesy of BioFire Diagnostics).
Image: FilmArray Direct from Positive Blood Culture Identification system (BCID) (Photo courtesy of BioFire Diagnostics).
The need for rapid antibiotic treatment of sepsis is well recognized, and the time to implementation of appropriate antibiotic therapy is critical in improving the outcome of sepsis.

Several methods have been developed to identify pathogens and some antibiotic resistance genes directly from positive blood culture bottles, which can shorten the time for final identification and susceptibility by as much as one to two days.

Medical laboratory scientists at the University of Florida (Gainesville, FL, USA) directly compared a multiplex polymerase chain reaction (PCR) method with a mass spectrometry system to identify organisms in positive blood cultures, between October 2012 and May 2013. They analyzed fluid from 161 positive blood cultures by both methods within 2 to 12 hours of the time the culture signaled positive in BacTec plus aerobic/F bottles incubated in a BacTec 9240 instrument (Becton, Dickinson and Company; Franklin Lakes, NJ, USA).

The two methods used to identify the bacteria were the FilmArray Direct from Positive Blood Culture system (BCID) (BioFire Diagnostics, Salt Lake City, UT, USA) and the VITEK Mass Spectrometry System (Vitek MS, bioMérieux; Durham, NC, USA). The BCID uses multiplex PCR to identify 90% to 95% of common isolates to the genus or species/complex level as well as three antibiotic resistance genes in approximately one hour. The prepared slides for the Vitek MS system were run in a bioMérieux mass spectrometer (Marcy l’Etoile, France).

A total of 132/133 (99%) of isolates that were in the FilmArray panel were identified correctly to the genus and/or species level. For those organisms that the FilmArray could identify to the species or species/complex level, 84/84 (100%) were correctly identified; for those that would only be expected to be identified to the genus level, 48/49 (98%) were identified correctly. The turnaround time for an individual FilmArray test is about an hour and if multiple samples need to be run, multiple instruments may be necessary.

Mass spectrometry correctly identified 142/151 (94%) monomicrobic cultures to the genus level and 137/151 (91%) to the species level. Vitek MS can process up to 48 specimens per slide in approximately an hour, but the actual time to perform a direct identification from a positive blood culture bottle would depend both on the filtration time and the workflow in the clinical microbiology setting to set up the slide and be read in the mass spectrometer.

The authors concluded that both the FilmArray and the VITEK MS mass spectrometry systems were highly accurate and can provide results in about an hour after blood cultures become positive, but the FilmArray is far easier to perform and to incorporate into laboratory workflow. The study was published online on March 22, 2014, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

University of Florida
Becton, Dickinson and Company
BioFire Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.